Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06759233

Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer

Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer and Its Immune Activation Mechanism Study

Status
Not Yet Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Zhongguang Luo, MD · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To clarify the efficacy and safety of endoscopic cryoablation combined with PD-1 monoclonal antibody treatment regimen in advanced gastric cancer.

Detailed description

This study is a single-center, single-arm, self-controlled, experimental, non-randomized exploratory clinical trial, aiming to enroll 15 patients with advanced gastric cancer. Each enrolled patient will be assigned a case number. This case number, along with the patient's name initials, will be recorded on every page of the case report form (CRF). Enrolled patients will receive local gastric ECAT (endoscopic cryoballoon ablation treatment) combined with PD-1 monoclonal antibody therapy for the evaluation of efficacy and safety, as well as immunological assessments of peripheral circulation and local tumor tissue. Patients will be followed during the treatment period and for six months after treatment termination for study observation.

Conditions

Interventions

TypeNameDescription
PROCEDUREendoscopic cryoballoon ablation treatment(ECAT)+PD-1ECAT: A cryoballoon with catheter is inserted along the endoscopic forceps channel, the balloon is placed on the surface of the tumor, and the balloon is dilated so that it fits snugly over the lesion. The freezing cycle is initiated and continued for 2-3 minutes, and then the balloon is rewarmed and frozen again for 2-3 minutes; the freeze-rewarm cycle is repeated twice. PD-1:The first PD-1 monoclonal antibody treatment in this study was given within 3 days before and after ECAT treatment, and subsequent treatment was given every three weeks according to the instructions.

Timeline

Start date
2025-05-15
Primary completion
2025-12-31
Completion
2026-12-31
First posted
2025-01-06
Last updated
2025-04-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06759233. Inclusion in this directory is not an endorsement.

Endoscopic Cryoablation Combined With PD-1 in Advanced Gastric Cancer (NCT06759233) · Clinical Trials Directory